Skin involvement in scleroderma--where histological and clinical scores meet

Rheumatology (Oxford). 2007 May;46(5):833-41. doi: 10.1093/rheumatology/kel451. Epub 2007 Jan 25.

Abstract

Objectives: A clinico-pathological study in diffuse systemic sclerosis (SSc) patients was performed to analyse whether the skin histological organization and the pro-fibrotic signals elicited by TGF-beta in fibroblasts vary according to the modified Rodnan skin score (mRSS).

Methods: Twenty-seven SSc patients underwent 45 skin biopsies with simultaneous measure of mRSS before or after treatment by immunosuppressive drugs, with or without autologous peripheral haematopoietic stem cell transplantation (HSCT).

Results: Double-blind optic microscopy analysis of the biopsies standard extracellular matrix stains allowed to define three histological subgroups: 6 with grade 1 weak fibrosis, 30 with grade 2 moderate fibrosis and 9 with grade 3 severe fibrosis. A significant (P < 0.0001) was identified between the grades of fibrosis and the mRSS. In skin fibroblast cultures, Smad3 phosphorylation levels, as well as mRNA steady-state levels of two transforming growth factor (TGF)-beta/Smad3 targets, COL1A2 and PAI-1, increased in parallel with the mRSS. When compared with pre-transplant values the degree of fibrosis observed after HSCT in the papillary and in the reticular dermis decreased in parallel with the fall in mRSS (n = 5 consecutive patients with repeated biopsies).

Conclusions: The histological extent of skin fibrosis correlates closely with the mRSS. Both parameters appeared to regress after HSCT. The extent of TGF-beta signalling activation in SSc skin fibroblasts appears to parallel the severity of disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biopsy
  • Cells, Cultured
  • Collagen / biosynthesis
  • Collagen / genetics
  • Collagen Type I
  • Combined Modality Therapy
  • Double-Blind Method
  • Female
  • Fibroblasts / metabolism
  • Fibrosis / metabolism
  • Fibrosis / pathology
  • Humans
  • Immunoenzyme Techniques
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation
  • Phosphorylation
  • Plasminogen Activator Inhibitor 1 / biosynthesis
  • Plasminogen Activator Inhibitor 1 / genetics
  • RNA, Messenger / genetics
  • Scleroderma, Diffuse / metabolism
  • Scleroderma, Diffuse / pathology*
  • Scleroderma, Diffuse / therapy
  • Severity of Illness Index*
  • Signal Transduction
  • Skin / metabolism
  • Skin / pathology*
  • Smad Proteins / metabolism
  • Smad3 Protein / metabolism
  • Transforming Growth Factor beta / metabolism

Substances

  • Collagen Type I
  • Immunosuppressive Agents
  • Plasminogen Activator Inhibitor 1
  • RNA, Messenger
  • SERPINE1 protein, human
  • SMAD3 protein, human
  • Smad Proteins
  • Smad3 Protein
  • Transforming Growth Factor beta
  • Collagen